HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery.

AbstractOBJECTIVE:
To compare the effectiveness of oral misoprostol and intravenous oxytocin in reducing blood loss in women undergoing indicated or elective cesarean delivery (CD) under spinal anesthesia.
METHODS:
In this prospective, double-blind pilot study, 56 parturients who received 5 IU of intravenous oxytocin after cord clamping were randomized to further receive either misoprostol orally and a placebo infusion intravenously or placebo orally and an oxytocin infusion intravenously.
RESULTS:
After adjustment was made for the sonographically estimated amniotic fluid volume, there was no statistical difference in blood loss between the 2 groups (mean+/-S.D., 1083+/-920 mL in the oxytocin group vs. 970+/-560 mL in the misoprostol group; P=.59).
CONCLUSION:
Oxytocin followed by oral misoprostol is as effective as an oxytocin injection followed by an oxytocin infusion in reducing postoperative blood loss after CD, and the protocol may be a safe, valuable, and cost-effective alternative to oxytocin alone. Visual estimation of intraoperative blood loss undervalues the effective value of misoprostol use by 30%.
AuthorsO Lapaire, M C Schneider, M Stotz, D V Surbek, W Holzgreve, I M Hoesli
JournalInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Int J Gynaecol Obstet) Vol. 95 Issue 1 Pg. 2-7 (Oct 2006) ISSN: 0020-7292 [Print] United States
PMID16934269 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Oxytocics
  • Misoprostol
  • Oxytocin
Topics
  • Administration, Oral
  • Adult
  • Cesarean Section (methods)
  • Double-Blind Method
  • Female
  • Hemostasis, Surgical (methods)
  • Humans
  • Injections, Intravenous
  • Misoprostol (therapeutic use)
  • Oxytocics (therapeutic use)
  • Oxytocin (therapeutic use)
  • Pilot Projects
  • Postpartum Hemorrhage (drug therapy)
  • Pregnancy
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: